ci 994 has been researched along with Bone Marrow Diseases in 1 studies
tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graziano, MJ | 1 |
| Pilcher, GD | 1 |
| Walsh, KM | 1 |
| Kasali, OB | 1 |
| Radulovic, L | 1 |
1 other study available for ci 994 and Bone Marrow Diseases
| Article | Year |
|---|---|
Preclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogs.
Topics: Animals; Antineoplastic Agents; Benzamides; Blood Chemical Analysis; Body Weight; Bone Marrow Diseas | 1997 |